Foekens JA - Search Results

1

Antiproliferative effects of suramin on androgen responsive tumour cells.

Berns EM, Schuurmans AL, Bolt J, Lamb DJ, Foekens JA, Mulder E. Berns EM, et al. Among authors: foekens ja. Eur J Cancer. 1990 Apr;26(4):470-4. doi: 10.1016/0277-5379(90)90018-o. Eur J Cancer. 1990. PMID: 2141513

2

Pleiotropic actions of suramin on the proliferation of human breast-cancer cells in vitro.

Foekens JA, Sieuwerts AM, Stuurman-Smeets EM, Dorssers LC, Berns EM, Klijn JG. Foekens JA, et al. Int J Cancer. 1992 May 28;51(3):439-44. doi: 10.1002/ijc.2910510317. Int J Cancer. 1992. PMID: 1592534 Free article.

3

Sporadic amplification of the insulin-like growth factor 1 receptor gene in human breast tumors.

Berns EM, Klijn JG, van Staveren IL, Portengen H, Foekens JA. Berns EM, et al. Among authors: foekens ja. Cancer Res. 1992 Feb 15;52(4):1036-9. Cancer Res. 1992. PMID: 1310636

4

Receptors for hormones and growth factors and (onco)-gene amplification in human ovarian cancer.

Berns EM, Klijn JG, Henzen-Logmans SC, Rodenburg CJ, van der Burg ME, Foekens JA. Berns EM, et al. Among authors: foekens ja. Int J Cancer. 1992 Sep 9;52(2):218-24. doi: 10.1002/ijc.2910520211. Int J Cancer. 1992. PMID: 1325950 Free article.

5

Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors.

Berns EM, Klijn JG, van Staveren IL, Portengen H, Noordegraaf E, Foekens JA. Berns EM, et al. Among authors: foekens ja. Eur J Cancer. 1992;28(2-3):697-700. doi: 10.1016/s0959-8049(05)80129-7. Eur J Cancer. 1992. PMID: 1350457

6

Epidermal growth factor receptor in ovarian tumours: correlation of immunohistochemistry with ligand binding assay.

Henzen-Logmans SC, Berns EM, Klijn JG, van der Burg ME, Foekens JA. Henzen-Logmans SC, et al. Among authors: foekens ja. Br J Cancer. 1992 Dec;66(6):1015-21. doi: 10.1038/bjc.1992.403. Br J Cancer. 1992. PMID: 1457340 Free PMC article.

7

c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer.

Berns EM, Klijn JG, van Putten WL, van Staveren IL, Portengen H, Foekens JA. Berns EM, et al. Among authors: foekens ja. Cancer Res. 1992 Mar 1;52(5):1107-13. Cancer Res. 1992. PMID: 1737370

8

Infrequent CDKN2 (MTS1/p16) gene alterations in human primary breast cancer.

Berns EM, Klijn JG, Smid M, van Staveren IL, Gruis NA, Foekens JA. Berns EM, et al. Among authors: foekens ja. Br J Cancer. 1995 Oct;72(4):964-7. doi: 10.1038/bjc.1995.442. Br J Cancer. 1995. PMID: 7547249 Free PMC article.

9

Prognostic factors and response to therapy in breast cancer.

Klijn JG, Berns EM, Foekens JA. Klijn JG, et al. Among authors: foekens ja. Cancer Surv. 1993;18:165-98. Cancer Surv. 1993. PMID: 8012996 Review.

10

The prognostic value of epidermal growth factor receptors, determined by both immunohistochemistry and ligand binding assays, in primary epithelial ovarian cancer: a pilot study.

van der Burg ME, Henzen-Logmans SC, Foekens JA, Berns EM, Rodenburg CJ, van Putten WL, Klijn JG. van der Burg ME, et al. Among authors: foekens ja. Eur J Cancer. 1993;29A(14):1951-7. doi: 10.1016/0959-8049(93)90451-k. Eur J Cancer. 1993. PMID: 8280488

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

411 results

Search Page

Filters